I found this article which may be of some use – “The basics of preclinical drug development for neurodegenerative disease indications”
The most useful part is probably the section at the end that discusses funding sources for preclinical drug development.

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2697630/?tool=pubmed